Why is Sanofi India falling/rising?

As of 23-Sep, Sanofi India Ltd is experiencing a decline in its stock price, currently at 5,000.00, reflecting a decrease of -14.15 or -0.28%. The stock has been on a downward trend, losing value for the last four consecutive days, with a total decline of -1.2% during this period. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish sentiment. Additionally, the stock has underperformed significantly over various time frames, with a year-to-date return of -18.03% and a one-year return of -30.70%. Despite having a high management efficiency with a return on equity (ROE) of 35.83% and low debt levels, the company's net sales and operating profit have shown poor growth rates, contributing to the negative sentiment surrounding the stock.
In the broader market context, Sanofi India's recent performance has been worse than the benchmark, with a one-week return of -0.59% compared to the Sensex's -0.34%. This underperformance is further highlighted by the stock's significant decline over the past three years, where it has returned -15.32% against the Sensex's +41.31%. The falling investor participation, as indicated by a -16.84% drop in delivery volume, suggests a lack of confidence among investors. The stock's premium valuation compared to peers, coupled with disappointing financial results and a flat performance in recent quarters, reinforces the negative outlook, making it less attractive to potential buyers in the current market environment.